ADP-ribosylation of transducin by pertussis toxin.

PubWeight™: 1.05‹?› | Rank: Top 15%

🔗 View Article (PMID 3863817)

Published in J Biol Chem on November 05, 1985

Authors

P A Watkins, D L Burns, Y Kanaho, T Y Liu, E L Hewlett, J Moss

Articles citing this

The family of bacterial ADP-ribosylating exotoxins. Clin Microbiol Rev (1995) 1.73

Role of the A subunit of pertussis toxin in alteration of Chinese hamster ovary cell morphology. Infect Immun (1987) 1.52

Activities of complete and truncated forms of pertussis toxin subunits S1 and S2 synthesized by Escherichia coli. Infect Immun (1987) 1.49

Engineering of genetically detoxified pertussis toxin analogs for development of a recombinant whooping cough vaccine. Infect Immun (1990) 1.08

Identification of amino acid residues essential for the enzymatic activities of pertussis toxin. Proc Natl Acad Sci U S A (1989) 1.05

The carboxy-terminal domain of Gs alpha is necessary for anchorage of the activated form in the plasma membrane. J Cell Biol (1990) 0.93

Assignment of functional domains involved in ADP-ribosylation and B-oligomer binding within the carboxyl terminus of the S1 subunit of pertussis toxin. Infect Immun (1994) 0.87

Light-dependent GTP-binding proteins in squid photoreceptors. Biochem J (1990) 0.82

Comparative analysis of cone and rod transducins using chimeric Gα subunits. Biochemistry (2012) 0.80

Dominant negative mutants of transducin-alpha that block activated receptor. Biochemistry (2006) 0.78

Failure of pertussis toxin to inhibit activation of guanylate cyclase by the heat-stable enterotoxin of Escherichia coli (STa) in the T84 cell line. Infect Immun (1989) 0.78

Signaling states of rhodopsin in rod disk membranes lacking transducin βγ-complex. Invest Ophthalmol Vis Sci (2012) 0.76

Articles by these authors

Tn5-induced mutations affecting virulence factors of Bordetella pertussis. Infect Immun (1983) 8.49

Human immunity to the meningococcus. 3. Preparation and immunochemical properties of the group A, group B, and group C meningococcal polysaccharides. J Exp Med (1969) 8.30

Virulence factors of Bordetella pertussis. Annu Rev Microbiol (1986) 6.41

Isolation of a brefeldin A-inhibited guanine nucleotide-exchange protein for ADP ribosylation factor (ARF) 1 and ARF3 that contains a Sec7-like domain. Proc Natl Acad Sci U S A (1996) 5.84

Complete amino acid analysis of proteins from a single hydrolysate. J Biol Chem (1976) 5.58

Hydrolysis of proteins with p-toluenesulfonic acid. Determination of tryptophan. J Biol Chem (1971) 5.28

Herbal medicines and perioperative care. JAMA (2001) 5.05

Induction of a novel morphological response in Chinese hamster ovary cells by pertussis toxin. Infect Immun (1983) 5.03

Phosphatidylinositol 4-phosphate 5-kinase alpha is a downstream effector of the small G protein ARF6 in membrane ruffle formation. Cell (1999) 4.98

Genetic diversity and relationships in populations of Bordetella spp. J Bacteriol (1986) 4.48

Molecular characterization of an operon required for pertussis toxin secretion. Proc Natl Acad Sci U S A (1993) 4.12

Predictive testing for Huntington's disease with use of a linked DNA marker. N Engl J Med (1988) 3.82

Extracytoplasmic adenylate cyclase of Bordetella pertussis. Proc Natl Acad Sci U S A (1976) 3.57

Pertussis toxin and extracytoplasmic adenylate cyclase as virulence factors of Bordetella pertussis. J Infect Dis (1984) 3.48

Activation of adenylate cyclase by choleragen. Annu Rev Biochem (1979) 3.16

Identification of the predominant substrate for ADP-ribosylation by islet activating protein. J Biol Chem (1983) 3.11

Hydrolysis of nicotinamide adenine dinucleotide by choleragen and its A protomer: possible role in the activation of adenylate cyclase. Proc Natl Acad Sci U S A (1976) 2.98

Lipid on capsular polysaccharides of gram-negative bacteria. J Biol Chem (1981) 2.91

Reproducible high yield sequencing of proteins electrophoretically separated and transferred to an inert support. J Biol Chem (1988) 2.88

Mechanism of action of choleragen. Evidence for ADP-ribosyltransferase activity with arginine as an acceptor. J Biol Chem (1977) 2.76

Studies on the meningococcal polysaccharides. II. Composition and chemical properties of the group B and group C polysaccharide. J Biol Chem (1971) 2.74

Adaptation of a conjugal transfer system for the export of pathogenic macromolecules. Trends Microbiol (1996) 2.74

Structural and immunological studies on the pneumococcal C polysaccharide. J Biol Chem (1967) 2.73

Inhibitors of receptor-mediated endocytosis block the entry of Bacillus anthracis adenylate cyclase toxin but not that of Bordetella pertussis adenylate cyclase toxin. Infect Immun (1988) 2.69

Comprehensive evaluation of 35 patients with lymphangioleiomyomatosis. Chest (1999) 2.65

Pertussis toxin-catalyzed ADP-ribosylation of transducin. Cysteine 347 is the ADP-ribose acceptor site. J Biol Chem (1985) 2.64

Nucleotide sequence and characterization of a repetitive DNA element from the genome of Bordetella pertussis with characteristics of an insertion sequence. J Gen Microbiol (1988) 2.46

The biotin-dependent enzymes. Adv Enzymol Relat Areas Mol Biol (1971) 2.45

Studies on the meningococcal polysaccharides. I. Composition and chemical properties of the group A polysaccharide. J Biol Chem (1971) 2.39

Mesenchymal precursor cells in the blood of normal individuals. Arthritis Res (2000) 2.37

Intracellular processing of endothelial nitric oxide synthase isoforms associated with differences in severity of cardiopulmonary diseases: cleavage of proteins with aspartate vs. glutamate at position 298. Proc Natl Acad Sci U S A (2000) 2.21

Functional incorporation of ganglioside into intact cells: induction of choleragen responsiveness. Proc Natl Acad Sci U S A (1976) 2.14

Rapid, reliable ligation-independent cloning of PCR products using modified plasmid vectors. Biotechniques (1992) 2.09

beta2-Adrenergic receptor regulation by GIT1, a G protein-coupled receptor kinase-associated ADP ribosylation factor GTPase-activating protein. Proc Natl Acad Sci U S A (1998) 2.08

Gene redundancy and pharmacological gene therapy: implications for X-linked adrenoleukodystrophy. Nat Med (1998) 2.08

Idiopathic nonspecific interstitial pneumonia: prognostic significance of cellular and fibrosing patterns: survival comparison with usual interstitial pneumonia and desquamative interstitial pneumonia. Am J Surg Pathol (2000) 2.07

Activation of adenylate cyclase by heat-labile Escherichia coli enterotoxin. Evidence for ADP-ribosyltransferase activity similar to that of choleragen. J Clin Invest (1978) 2.07

Molecular identification of ADP-ribosylation factor mRNAs and their expression in mammalian cells. J Biol Chem (1991) 1.99

Acetyl coenzyme A carboxylase system of Escherichia coli. Purification and properties of the biotin carboxylase, carboxyltransferase, and carboxyl carrier protein components. J Biol Chem (1974) 1.99

Mortality variation across Australia: descriptive data for states and territories, and statistical divisions. Aust N Z J Public Health (2000) 1.98

Muramic acid phosphate as a component of the mucopeptide of Gram-positive bacteria. J Biol Chem (1967) 1.94

Acetyl coenzyme A carboxylase. Curr Top Cell Regul (1974) 1.94

Extrapulmonary lymphangioleiomyomatosis (LAM): clinicopathologic features in 22 cases. Hum Pathol (2000) 1.93

Bordetella pertussis adenylate cyclase toxin and hemolytic activities require a second gene, cyaC, for activation. J Bacteriol (1991) 1.90

Cross-antigenicity and immunogenicity between capsular polysaccharides of group C Neisseria meningitidis and of Escherichia coli K92. J Infect Dis (1977) 1.84

Intracellular localization of the dermonecrotic toxin of Bordetella pertussis. Infect Immun (1979) 1.83

Oxidation of either methionine 351 or methionine 358 in alpha 1-antitrypsin causes loss of anti-neutrophil elastase activity. J Biol Chem (2000) 1.82

Identification of antigens and antibodies specific for Pneumocystis carinii. J Immunol (1988) 1.81

Cytokine-mediated transcriptional induction of the human inducible nitric oxide synthase gene requires both activator protein 1 and nuclear factor kappaB-binding sites. J Biol Chem (1998) 1.81

Association of phosphatidylinositol 3-kinase with nuclear transcription sites in higher plants. Plant Cell (2000) 1.81

Internal lysine palmitoylation in adenylate cyclase toxin from Bordetella pertussis. Science (1994) 1.78

Purification and cloning of a brefeldin A-inhibited guanine nucleotide-exchange protein for ADP-ribosylation factors. J Biol Chem (1999) 1.78

Activation of rat brain phospholipase D by ADP-ribosylation factors 1,5, and 6: separation of ADP-ribosylation factor-dependent and oleate-dependent enzymes. Proc Natl Acad Sci U S A (1994) 1.74

Activation by thiol of the latent NAD glycohydrolase and ADP-ribosyltransferase activities of Bordetella pertussis toxin (islet-activating protein). J Biol Chem (1983) 1.74

Phenotype of patients with peroxisomal disorders subdivided into sixteen complementation groups. J Pediatr (1995) 1.73

Lymphangioleiomyomatosis: what do we know and what are we looking for? Eur Respir Rev (2011) 1.73

Binding of C-reactive protein to chromatin and nucleosome core particles. A possible physiological role of C-reactive protein. J Biol Chem (1984) 1.73

Prophylaxis against ampicillin-associated diarrhea with a lactobacillus preparation. Am J Hosp Pharm (1979) 1.72

Agglutinating monoclonal antibodies that specifically recognize lipooligosaccharide A of Bordetella pertussis. Infect Immun (1988) 1.71

Adrenoleukodystrophy: incidence, new mutation rate, and results of extended family screening. Ann Neurol (2001) 1.71

Binding of pertussis toxin to eucaryotic cells and glycoproteins. Infect Immun (1989) 1.71

N-Acetyl-D-galactosamine-inhibitable adherence lectin of Entamoeba histolytica. I. Partial purification and relation to amoebic virulence in vitro. J Infect Dis (1985) 1.67

ADP-ribosylation of adenylate cyclase by pertussis toxin. Effects on inhibitory agonist binding. J Biol Chem (1984) 1.67

Lymphangioleiomyomatosis: CT of diurnal variation of lymphangioleiomyomas. Radiology (2001) 1.67

Stimulation of choleragen enzymatic activities by GTP and two soluble proteins purified from bovine brain. J Biol Chem (1988) 1.67

Alteration of the copy number and deletion of mitochondrial DNA in human hepatocellular carcinoma. Br J Cancer (2004) 1.64

beta-Arrestin-mediated ADP-ribosylation factor 6 activation and beta 2-adrenergic receptor endocytosis. J Biol Chem (2001) 1.63

Identification and localization of two brefeldin A-inhibited guanine nucleotide-exchange proteins for ADP-ribosylation factors in a macromolecular complex. Proc Natl Acad Sci U S A (2000) 1.62

Cytohesin-1, a cytosolic guanine nucleotide-exchange protein for ADP-ribosylation factor. Proc Natl Acad Sci U S A (1997) 1.62

Pertussis toxin and target eukaryotic cells: binding, entry, and activation. FASEB J (1992) 1.62

Effect of myristoylation on GTP-dependent binding of ADP-ribosylation factor to Golgi. J Biol Chem (1993) 1.61

Binding sites of the 9- and 14-kilodalton heterodimeric protein subunit of the signal recognition particle (SRP) are contained exclusively in the Alu domain of SRP RNA and contain a sequence motif that is conserved in evolution. Mol Cell Biol (1991) 1.61

Quantitative studies of inhibitors of ADP-ribosylation in vitro and in vivo. J Biol Chem (1989) 1.61

Tryptase levels are not increased during vancomycin-induced anaphylactoid reactions. Anesthesiology (1998) 1.61

Search for supersymmetry using final states with one lepton, jets, and missing transverse momentum with the ATLAS detector in √s=7 TeV pp collisions. Phys Rev Lett (2011) 1.60

Comparative studies on the binding properties of human and rabbit C-reactive proteins. J Immunol (1980) 1.59

Toxins of Vibrio cholerae and Escherichia coli stimulate adenyl cyclase in rat fat cells. Nature (1974) 1.58

Specific high-affinity binding of host cell proteins to the 3' region of rubella virus RNA. New Biol (1990) 1.57

Antihistamine prophylaxis permits rapid vancomycin infusion. Crit Care Med (1999) 1.57

Phosphatidylinositol-4-phosphate 5-kinase localized on the plasma membrane is essential for yeast cell morphogenesis. J Biol Chem (1998) 1.56

Experimental infection of mongrel dogs with Giardia lamblia cysts and cultured trophozoites. J Infect Dis (1982) 1.56

Primary structure of human C-reactive protein. J Biol Chem (1979) 1.55

Bone marrow-derived mesenchymal stem cells remain host-derived despite successful hematopoietic engraftment after allogeneic transplantation in patients with lysosomal and peroxisomal storage diseases. Exp Hematol (1999) 1.55

Correction of the PNH defect by GPI-anchored protein transfer. Blood (1998) 1.55

Hydroxylamine-stable covalent linkage of myristic acid in G0 alpha, a guanine nucleotide-binding protein of bovine brain. Biochem Biophys Res Commun (1987) 1.55

Activation of Helicobacter pylori VacA toxin by alkaline or acid conditions increases its binding to a 250-kDa receptor protein-tyrosine phosphatase beta. J Biol Chem (1999) 1.54

Brefeldin A-inhibited guanine nucleotide-exchange activity of Sec7 domain from yeast Sec7 with yeast and mammalian ADP ribosylation factors. Proc Natl Acad Sci U S A (1998) 1.54

Angioplasty and STent for Renal Artery Lesions (ASTRAL trial): rationale, methods and results so far. J Hum Hypertens (2007) 1.54

Choleragen activation of solubilized adenylate cyclase: requirement for GTP and protein activator for demonstration of enzymatic activity. Proc Natl Acad Sci U S A (1977) 1.54

Immunohistochemical study of matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs) in pulmonary lymphangioleiomyomatosis (LAM). Hum Pathol (1997) 1.53

Role of the A subunit of pertussis toxin in alteration of Chinese hamster ovary cell morphology. Infect Immun (1987) 1.52

Conservative management of fibroadenoma of the breast. Br J Surg (1996) 1.51

Interaction of choleragen with the oligosaccharide of ganglioside GM1: evidence for multiple oligosaccharide binding sites. Biochemistry (1978) 1.50

Plasma catecholamines in stress and exercise. JAMA (1980) 1.50

Solubilization and partial purification of cellulose synthetase from Phaseolus aureus. J Biol Chem (1970) 1.50

Lymphangioleiomyomatosis: abdominopelvic CT and US findings. Radiology (2000) 1.49